Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2026)

Mangoceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $147451.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 469.77% year-over-year to $147451.0; the TTM figure through Mar 2026 stood at $147451.0 (up 469.77% YoY), while the FY2025 annual figure was $156642.0, down 58.0% from the prior year.
• Other Accumulated Expenses came in at $147451.0 for Q1 2026 at Mangoceuticals, down from $156642.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $400000.0 in Q2 2024 to a low of $9175.0 in Q2 2025.
• A 3-year average of $205978.9 and a median of $158663.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses sank 97.71% in 2025 and soared 469.77% in 2026, its largest moves.
• Mangoceuticals' Other Accumulated Expenses stood at $373000.0 in 2024, then sank by 58.0% to $156642.0 in 2025, then retreated by 5.87% to $147451.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $147451.0, $156642.0, and $160684.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison